Cancer
Exploring the Link Between Cell Death, Aging, and Cancer Research
As the global population ages, understanding the biological processes associated with senescence becomes increasingly critical in the fight against cancer...
Are Flame Retardants in Battery Enclosures Doing More Harm Than Good?
As the prevalence of lithium-ion battery usage continues to soar, concerns about their safety have become increasingly prominent. These batteries...
Emerging Triple Inhibitor Combination Targets Malignant Peripheral Nerve Sheath Tumors: A Breakthrough in Precision Medicine
A groundbreaking multicenter collaboration spearheaded by the Bellvitge Biomedical Research Institute (IDIBELL), the Catalan Institute of Oncology (ICO), and the...
Rice University and MD Anderson Collaborate to Secure Kleberg Medical Grant for Brain Metastasis Research
Rice University chemist Han Xiao and cancer biologist Dihua Yu from The University of Texas MD Anderson Cancer Center have...
Exploring the Potential of Fecal Microbiota Transplantation to Enhance Recovery in Stem Cell Transplant Patients
A groundbreaking study has unveiled new possibilities for utilizing oral fecal microbiota transplantation (FMT) in the prevention of graft-versus-host disease...
Breakthrough Adjuvant Delivery System Set to Boost Cancer Vaccine Efficacy
Researchers at the Terasaki Institute for Biomedical Innovation have made substantial strides in the realm of cancer vaccine development with...
Empowering T Cells: A New Approach to Cancer Immunotherapy
Recent research from the University of Pittsburgh has unveiled a groundbreaking method for growing T cells in laboratory conditions, enhancing...
Damon Runyon Cancer Research Foundation Grants $3.2 Million to Pioneering Early-Career Scientists
The Damon Runyon Cancer Research Foundation has made headlines with its announcement of the 2025 Damon Runyon-Rachleff Innovation Award recipients,...
Enhanced Survival Rates Observed with Anatomic Lung Resection in Early-Stage Lung Cancer Patients
New research unveiled at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting has significant implications for the surgical treatment...
Synergistic Impact of Dual-Targeted Therapies with Chemotherapy Achieves Promising Response Rates in BRAF-Mutated Metastatic Colorectal Cancer
In recent advancements in the treatment of metastatic colorectal cancer (mCRC) characterized by BRAF V600E mutations, researchers have announced compelling...
Blood Test from Alliance Trial Reveals Anti-Inflammatory Drug’s Potential to Reduce Colon Cancer Recurrence Risks
The Alliance for Clinical Trials in Oncology has recently unveiled compelling findings from a randomized phase III clinical trial focused...
Blood Test May Inform Use of Celecoxib to Lower Colon Cancer Recurrence Risk
A recent study from Dana-Farber Brigham Cancer Center has unveiled significant findings regarding the treatment of stage 3 colon cancer,...
Revolutionary Dyes Enhance Photothermal Cancer Treatment and Diagnostics
In a groundbreaking study from Tokyo Metropolitan University, a team of researchers has unveiled a revolutionary dye engineered to absorb...
Sex-based differences in lung cancer
Lung cancer remains one of the most ominous health threats worldwide, capturing the concern of scientists, physicians, and the general...
Scientists Develop Peptides to Boost Drug Effectiveness
In a pivotal breakthrough for cancer treatment, researchers have developed an innovative technology that utilizes meticulously designed peptides to transform...
University Hospitals Seidman Cancer Center Pioneers Use of Varian Ethos 2.0 for Cancer Patient Care in North America
CLEVELAND – In a transformative advancement for cancer treatment, the University Hospitals Seidman Cancer Center in Cleveland, Ohio, has integrated...
Exclusive Insights: Dana-Farber Researchers Uncover Factors Influencing Cell Therapy Efficacy in Leukemia
Boston’s Dana-Farber Cancer Institute has made a significant advancement in understanding the complex landscape of acute myeloid leukemia (AML) treatment,...
Combination of Radiotherapy and Cetuximab Show Promise in Enhancing Outcomes for Select Head and Neck Cancer Patients Post-Surgery
Recent advancements in the field of oncology have shed light on the potential benefit of integrating cetuximab, an epidermal growth...
New Insights from Moffitt Study highlight the Potential of Genomic Testing in Enhancing Prostate Cancer Treatment
In the ever-evolving realm of oncology, new research is continuously reshaping our understanding of cancer treatment. A recent systematic review...
Exploring Potassium Channel Inhibition: A Promising Avenue for Brain Tumor Therapeutics
In a groundbreaking study, scientists at The Hospital for Sick Children (SickKids) have made significant strides towards the development of...
